Clinical trial
Humira® 40mg Syringe 0.8mL Subcutaneous Injection Special Investigation in Patients With Intestinal Behcet's Disease
NCT01960790 is registered in ClinicalTrials.gov with AbbVie as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Humira® 40mg Syringe 0.8mL Subcutaneous Injection Special Investigation in Patients With Intestinal Behcet's Disease
- Lead sponsor
- AbbVie
- Phase
- Observational
- Overall status
- Completed
- Start date
- May 25, 2013
- Completion date
- May 15, 2017
- Enrollment
- 473 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
behcet's disease